Moving Science Podcast: The current and future role of MRI for diagnosis and prognosis in MS.

Moving Science Podcast Episode 8: The current and future role of MRI for diagnosis and prognosis in MS. Host: Prof. Olga Ciccarelli, UCL Queen Square Institute of Neurology and Neuroinflammation in London. Speaker: Prof. Massimo Filippi, Vita-Salute San Raffaele University in Milan, Italy This episode will be interesting to anyone keen to learn about the current standards of care and recent advancements in the field of MRI and MS, including the recent revision of the McDonald criteria, AI-driven and automated MRI, and an outlook to the future. Join us as our speakers discuss the need for a "cultural switch" in MS – a shift already prominent in other disease areas such as Alzheimer's and oncological diseases. This change aims to enhance our understanding of MS pathophysiology and emphasizes acting on biomarker findings for early diagnosis and treatment to prevent disease progression. 🎧 Tune in to gain valuable insights and stay updated in the field. Subscribe to our YouTube channel now: https://www.youtube.com/user/roche?su... Get in touch with us: https://www.roche.com/   / roche     / roche     / roche     / roche   Roche has been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally. Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. For more information and insights visit: https://www.roche.com/